JENNIFER BECHER: Open Payments
NPI 1174730550 · VINCENNES, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$610 in 31 payments from 13 companies in 2025. Trend: 2023 $326 · 2024 $366 · 2025 $610
Food & beverage: $610
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 7 | $125 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $100 |
| Axsome Therapeutics, Inc. | 3 | $89 |
| AstraZeneca Pharmaceuticals LP | 3 | $54 |
| Lilly USA, LLC | 3 | $51 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $47 |
| ABBVIE INC. | 2 | $37 |
| Amgen Inc. | 1 | $23 |
| SpringWorks Therapeutics, Inc. | 1 | $20 |
| Lundbeck LLC | 1 | $19 |
Products named: SUBLOCADE, CAPLYTA, Auvelity, Kerendia, BREZTRI, QULIPTA, REXULTI, MOUNJARO.
Industry payments across IN — which companies pay providers there.
